Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CHF | -.--% | -.--% | -.--% |
06-05 | Collective bargaining partners in the chemical industry adjourn again | DP |
05-31 | Wacker Chemie AG completed the acquisition of Assets of Bio Med Sciences Inc. | CI |
Sales 2024 * | 6.14B 6.63B 5.94B 9.11B | Sales 2025 * | 6.6B 7.13B 6.39B 9.8B | Capitalization | 4.96B 5.36B 4.8B 7.36B |
---|---|---|---|---|---|
Net income 2024 * | 225M 243M 218M 334M | Net income 2025 * | 413M 446M 399M 613M | EV / Sales 2024 * | 0.85 x |
Net Debt 2024 * | 251M 272M 243M 373M | Net Debt 2025 * | 197M 213M 191M 292M | EV / Sales 2025 * | 0.78 x |
P/E ratio 2024 * |
22.3
x | P/E ratio 2025 * |
12.4
x | Employees | - |
Yield 2024 * |
2.47% | Yield 2025 * |
4.07% | Free-Float | 31.67% |
Latest transcript on Wacker Chemie AG
Managers | Title | Age | Since |
---|---|---|---|
Christian Hartel
CEO | Chief Executive Officer | 53 | 15-10-31 |
Jörg Hoffmann
IRC | Investor Relations Contact | - | - |
Thomas Renner
PRN | Corporate Officer/Principal | - | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 73 | 08-05-07 | |
Matthias Biebl
BRD | Director/Board Member | 58 | 08-05-07 |
Susanne Weiss
BRD | Director/Board Member | 63 | 08-05-07 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.64% | 19.47B | |
+4.10% | 4.25B | |
+17.20% | 1.62B | |
-4.54% | 1.22B | |
+18.59% | 957M | |
-16.94% | 646M | |
-37.78% | 553M | |
-22.29% | 262M | |
-5.64% | 252M |
- Stock Market
- Equities
- WCH Stock
- WCH Stock